
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5601876
[patent_doc_number] => 20060292221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'TIMED-RELEASE COMPRESSION-COATED SOLID COMPOSITION FOR ORAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 11/463570
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15198
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292221.pdf
[firstpage_image] =>[orig_patent_app_number] => 11463570
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/463570 | TIMED-RELEASE COMPRESSION-COATED SOLID COMPOSITION FOR ORAL ADMINISTRATION | Aug 8, 2006 | Abandoned |
Array
(
[id] => 4657192
[patent_doc_number] => 20080026053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Capsule containing granular pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/494616
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11336
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026053.pdf
[firstpage_image] =>[orig_patent_app_number] => 11494616
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/494616 | Capsule containing granular pharmaceutical compositions | Jul 27, 2006 | Abandoned |
Array
(
[id] => 4598671
[patent_doc_number] => 07976872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => 'Method for distributing a pharmaceutically active compound in an excipient'
[patent_app_type] => utility
[patent_app_number] => 11/491844
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2483
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/976/07976872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491844
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491844 | Method for distributing a pharmaceutically active compound in an excipient | Jul 23, 2006 | Issued |
Array
(
[id] => 6245253
[patent_doc_number] => 20100135907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Oral Drug Compliance Monitoring Using Sound Detection'
[patent_app_type] => utility
[patent_app_number] => 11/989225
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 1995
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20100135907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989225 | Oral Drug Compliance Monitoring Using Sound Detection | Jul 20, 2006 | Abandoned |
Array
(
[id] => 5074884
[patent_doc_number] => 20070014859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate'
[patent_app_type] => utility
[patent_app_number] => 11/486324
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4471
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11486324
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/486324 | Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5241842
[patent_doc_number] => 20070020334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Benzimidazole formulation'
[patent_app_type] => utility
[patent_app_number] => 11/483736
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10967
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11483736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/483736 | Benzimidazole formulation | Jul 10, 2006 | Abandoned |
Array
(
[id] => 4994244
[patent_doc_number] => 20070009589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'EXTENDED RELEASE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/428936
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4512
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009589.pdf
[firstpage_image] =>[orig_patent_app_number] => 11428936
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/428936 | EXTENDED RELEASE COMPOSITIONS | Jul 5, 2006 | Abandoned |
Array
(
[id] => 6619494
[patent_doc_number] => 20100324132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING'
[patent_app_type] => utility
[patent_app_number] => 11/993827
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13222
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324132.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993827 | METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5022272
[patent_doc_number] => 20070148238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Dosage forms for movement disorder treatment'
[patent_app_type] => utility
[patent_app_number] => 11/474116
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 91819
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474116 | Dosage forms for movement disorder treatment | Jun 22, 2006 | Abandoned |
Array
(
[id] => 5141405
[patent_doc_number] => 20070003621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Dosage forms for movement disorder treatment'
[patent_app_type] => utility
[patent_app_number] => 11/474524
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 91825
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003621.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474524 | Dosage forms for movement disorder treatment | Jun 22, 2006 | Abandoned |
Array
(
[id] => 5687845
[patent_doc_number] => 20060286160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Nicotine transdermal delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/455740
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11547
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455740
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455740 | Nicotine transdermal delivery system | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5921592
[patent_doc_number] => 20060240099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'High-amylose starch'
[patent_app_type] => utility
[patent_app_number] => 11/453873
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2784
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240099.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453873 | High-amylose starch | Jun 15, 2006 | Abandoned |
Array
(
[id] => 5141399
[patent_doc_number] => 20070003615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Nanoparticulate clopidogrel and aspirin combination formulations'
[patent_app_type] => utility
[patent_app_number] => 11/450890
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15725
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003615.pdf
[firstpage_image] =>[orig_patent_app_number] => 11450890
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/450890 | Nanoparticulate clopidogrel and aspirin combination formulations | Jun 11, 2006 | Abandoned |
Array
(
[id] => 5056449
[patent_doc_number] => 20070059371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Nanoparticulate ebastine formulations'
[patent_app_type] => utility
[patent_app_number] => 11/448984
[patent_app_country] => US
[patent_app_date] => 2006-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13662
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059371.pdf
[firstpage_image] =>[orig_patent_app_number] => 11448984
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/448984 | Nanoparticulate ebastine formulations | Jun 7, 2006 | Abandoned |
Array
(
[id] => 13104863
[patent_doc_number] => 10071060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Asymmetrically coated table
[patent_app_type] => utility
[patent_app_number] => 11/443666
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 26
[patent_no_of_words] => 4495
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11443666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/443666 | Asymmetrically coated table | May 29, 2006 | Issued |
Array
(
[id] => 5699645
[patent_doc_number] => 20060216329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Drug delivery system and method'
[patent_app_type] => utility
[patent_app_number] => 11/442580
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9725
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216329.pdf
[firstpage_image] =>[orig_patent_app_number] => 11442580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/442580 | Drug delivery system and method | May 25, 2006 | Abandoned |
Array
(
[id] => 4459007
[patent_doc_number] => 07879361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Nanoparticles for drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/442192
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 22426
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879361.pdf
[firstpage_image] =>[orig_patent_app_number] => 11442192
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/442192 | Nanoparticles for drug delivery | May 25, 2006 | Issued |
Array
(
[id] => 4639125
[patent_doc_number] => 08017152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Cores and microcapsules suitable for parenteral administration as well as process for their manufacture'
[patent_app_type] => utility
[patent_app_number] => 11/439602
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14478
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017152.pdf
[firstpage_image] =>[orig_patent_app_number] => 11439602
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/439602 | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | May 23, 2006 | Issued |
Array
(
[id] => 4812912
[patent_doc_number] => 20080193543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Drug Delivery Formulations For Targeted Delivery'
[patent_app_type] => utility
[patent_app_number] => 11/914394
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16188
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914394
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914394 | Drug Delivery Formulations For Targeted Delivery | May 16, 2006 | Abandoned |
Array
(
[id] => 5784495
[patent_doc_number] => 20060204583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Chemoembolisation'
[patent_app_type] => utility
[patent_app_number] => 11/434274
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5694
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204583.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434274
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434274 | Chemoembolisation | May 15, 2006 | Issued |